17 September 2019

By Dr Wendy Winnall - PCFA Research Team

Prostate cancer with low PSA

When back-to-back articles are published in one of the world’s top scientific journals, Nature, we know that something exciting is going on. Scientists from two different laboratories have discovered the mechanisms by which a gene called FOXA1 drives prostate cancer formation. FOXA1 is therefore a potential target for new drugs to block growth of prostate cancer.

To read the full article just log into the PCFA Online Community.

If you're not already a member, it is free and easy to join.

Join Online Community Button